Stay updated with breaking news from Alexander Eggermont. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Agenus Inc. , a leader in developing novel immunological agents to treat various cancers, today announced that the Company will host a corporate event to discuss advancements in its...
Leveraging the transformative potential of TSL-based tumor targetingSupporting the progress of Thermosome's clinical candidate THE001
AGEN earnings call for the period ending September 30, 2022.
Quotable quotes heard by <em>MedPage Today</em>'s reporters
Preoperative immunotherapy combo in dMMR disease yields major pathologic response in 95%